BULLOCK JIM
Consulente / Consigliere presso Solas Bioventures (mayfield) LLC
Profilo
Jim served as the President and Chief Executive Officer of Zyga Technology, Inc. (“Zyga Technology”), a privately-held medical device company focused on products that treat conditions of the lumbar spine, until January 2018, when RTI Surgical, Inc. (NASDAQ: RTIX) acquired Zyga Technology.
Prior to that, he served for six years as President and Chief Executive Officer of Atritech, Inc. Atritech was a privately-held cardiovascular manufacturing company that was acquired by Boston Scientific (NYSE: BSX).
Prior to that, he served for nine years as President and Chief Executive Officer and was a member of the board of directors of Endocardial Solutions, Inc.(NASDAQ: ECSI), a cardiac-focused medical device company that was acquired by St. Jude Medical, which was itself acquired by Abbott Laboratories (NYSE: ABT).
He also served in that position at Stuart Medical, Inc., and began his career working in a variety of sales and marketing leadership positions at Baxter Healthcare, Inc. (NYSE: BAX), and American Hospital Supply Corporation.
In addition to his service on the board of Endocardial Solutions, Inc., Mr. Bullock has also served on the boards of directors of several private companies.
Posizioni attive di BULLOCK JIM
Società | Posizione | Inizio |
---|---|---|
Solas Bioventures (mayfield) LLC
Solas Bioventures (mayfield) LLC Investment ManagersFinance Solas BioVentures (mayfield) LLC (Solas BioVentures) is a venture capital firm founded in 2012 by David Adair and Mark Hackett JD. The firm is headquartered in Chattanooga, Tennessee. | Consulente / Consigliere | - |
Precedenti posizioni note di BULLOCK JIM
Società | Posizione | Fine |
---|---|---|
Endocardial Solutions, Inc.
Endocardial Solutions, Inc. Medical SpecialtiesHealth Technology Endocardial Solutions, Inc. designs, develops and manufactures a minimally invasive diagnostic system that diagnoses within the span of a few heartbeats, arrhythmia, a potentially fatal abnormal heart rhythm. The company's EnSite catheters and clinical workstations produce a high-resolution, real-time, three-dimensional color display of electrical activity in the heart chamber, thus allowing electrophysiologists to locate and diagnose tachycardia in real-time and to determine the course of treatment. It was founded in 1992. The company is located in St. Paul, MN. | Amministratore Delegato | - |
Atritech, Inc.
Atritech, Inc. Hospital/Nursing ManagementHealth Services Atritech, Inc. is a private company that provides therapies to treat patients suffering from atrial fibrillation. They offer their services to clients who are at increased risk of stroke by offering permanent alternatives to medications. The company was founded in 2000 and is headquartered in Plymouth, MN. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Solas Bioventures (mayfield) LLC
Solas Bioventures (mayfield) LLC Investment ManagersFinance Solas BioVentures (mayfield) LLC (Solas BioVentures) is a venture capital firm founded in 2012 by David Adair and Mark Hackett JD. The firm is headquartered in Chattanooga, Tennessee. | Finance |
Atritech, Inc.
Atritech, Inc. Hospital/Nursing ManagementHealth Services Atritech, Inc. is a private company that provides therapies to treat patients suffering from atrial fibrillation. They offer their services to clients who are at increased risk of stroke by offering permanent alternatives to medications. The company was founded in 2000 and is headquartered in Plymouth, MN. | Health Services |
Endocardial Solutions, Inc.
Endocardial Solutions, Inc. Medical SpecialtiesHealth Technology Endocardial Solutions, Inc. designs, develops and manufactures a minimally invasive diagnostic system that diagnoses within the span of a few heartbeats, arrhythmia, a potentially fatal abnormal heart rhythm. The company's EnSite catheters and clinical workstations produce a high-resolution, real-time, three-dimensional color display of electrical activity in the heart chamber, thus allowing electrophysiologists to locate and diagnose tachycardia in real-time and to determine the course of treatment. It was founded in 1992. The company is located in St. Paul, MN. | Health Technology |
- Borsa valori
- Insiders
- BULLOCK JIM